Global /Taiwan /Healthcare /Medical Devices /6661

Welgene Biotech Co.,Ltd.

6661

• TPEX: 6661 • Delayed

18.00TWD -0.8%

0.5689 USD

As of 20 June 2026, Welgene Biotech Co.,Ltd. has a market cap of $13.38M USD, ranking #39699 globally and #2306 in Taiwan. It ranks #3545 in the Healthcare sector, and #752 in the Medical Devices industry.

Global Rank

39699

Country Rank

2306

Sector Rank

3545

Industry Rank

752

Key Stats

Market Cap

$13.38MUSD

422.97M TWD

Enterprise Value

$12.21MUSD

386.44M TWD

Revenue (TTM)

$11.89MUSD

375.94M TWD

EBITDA (TTM)

$882.35KUSD

27.92M TWD

Net Income (TTM)

$42.06KUSD

1.33M TWD

EBITDA Margin

7.4%

Profit Margin

0.4%

PE Ratio

318.0

PS Ratio

1.1

PB Ratio

1.5

EV/EBITDA

13.9

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Yi Xing Lin open_in_new

Founded

2003

Website

welgene.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-2.2%	-6.2%	-7.2%	-6.9%	-2.4%	-10%	-19%	-35%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6661 威健股份有限公司 Ordinary Shares ISIN: TW0006661002 Shares Out.: Shares Outstanding: 23.304M¹ Shares Float: 12.971M² TV: TradingView: TPEX: 6661 SA: Stock Analysis: TPEX: 6661 YF: Yahoo Finance: 6661.TWO GF: Google Finance: TPEX: 6661 BA: Barron's: 6661 MS: Morningstar: ROCO: 6661	18.00 TWD	TV: TradingView: TPEX: 6661 SA: Stock Analysis: TPEX: 6661 YF: Yahoo Finance: 6661.TWO GF: Google Finance: TPEX: 6661 BA: Barron's: 6661 MS: Morningstar: ROCO: 6661

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$667.4M 21.1B TWD 5K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$377.01M 11.92B TWD 3K%	8.3	Taiwan
United Orthopedic Corp. TPEX: 4129	$301.92M 9.55B TWD 2K%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$254.21M 8.04B TWD 2K%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$190.77M 6.03B TWD 1K%	16.4	Taiwan
Formosa Optical Technology Co.,Ltd. TPEX: 5312	$184.81M 5.84B TWD 1K%	15.2	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 1M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 1M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 1M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 946K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 902K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 762K%	22.2	Ireland

chevron_leftBack